Shares of Neogen Corp (NEOG) surged by 5.06% on Monday despite the company reporting disappointing first-quarter fiscal 2025 earnings that missed analysts' estimates. The stock's rally was driven by stronger-than-expected revenue growth and positive signals from certain key product segments.
While Neogen reported adjusted earnings per share of 7 cents, down 36.4% year-over-year and missing the Zacks Consensus Estimate by 30%, the company's revenues of $217 million surpassed expectations by 0.4%. The Food Safety segment, which accounts for a significant portion of Neogen's business, saw core revenue growth of 1.1%, led by strong performance in biosecurity and indicator testing, as well as the Petrifilm product line.
Despite challenges in the Animal Safety segment and margin pressures due to higher costs, investors appear to have focused on the positive revenue growth and the company's ability to navigate headwinds like foreign currency fluctuations. The market's reaction suggests optimism about Neogen's long-term growth prospects, particularly in its core Food Safety business.
Comments